Peptonic Medical

A liquidity provider's aim is to improve the liquidity of a share and reduce the spread between the bidding and asking price. Mangold Fondkommission's assignment commences on September 27, 2023.

Mangold will fulfill its assignment as liquidity provider to ensure the possibility of trading in Peptonic's share every day by continuously placing trading records on each purchase and sales page in the order book. A liquidity provider aims to create a more accurate pricing of a company"s share, which in turn gives a more accurate valuation of the company and allows for an improved trading volume in the share.